Dr. Perry Shieh, MD, PhD
Claim this profileDavid Geffen School of Medicine at UCLA
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
15 reported clinical trials
16 drugs studied
Area of expertise
1Muscular Dystrophy
dystrophin positive
GNE positive
2Duchenne Muscular Dystrophy
dystrophin positive
Affiliated Hospitals
Clinical Trials Perry Shieh, MD, PhD is currently running
Tideglusib
for Myotonic Dystrophy
This trial tests tideglusib, a medication, in children and adolescents with Congenital or Childhood Onset Myotonic Dystrophy. It aims to improve muscle function by targeting specific body processes. The study includes both those who participated in a previous study and those who have not been treated before.
Recruiting1 award Phase 2 & 31 criteria
DYNE-251
for Duchenne Muscular Dystrophy
This trial tests DYNE-251, an IV drug, in people with Duchenne muscular dystrophy who can benefit from exon 51 skipping. The drug aims to help their muscles by increasing the dystrophin protein. It works by skipping a faulty part of their gene to produce more of this important protein. Eteplirsen (Exondys 51) was the first drug approved for exon 51 skipping in Duchenne muscular dystrophy.
Recruiting0 awards Phase 1 & 2
More about Perry Shieh, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Perry Shieh, MD, PhD has experience with
- Placebo
- Tideglusib
- Motor Outcomes To Validate Evaluations In FSHD (MOVE FSHD)
- Delandistrogene Moxeparvovec
- ABC008
- Retrospective Study
Breakdown of trials Perry Shieh, MD, PhD has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Myotonic Dystrophy
Inclusion Body Myositis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Perry Shieh, MD, PhD specialize in?
Perry Shieh, MD, PhD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved dystrophin positive patients, or patients who are GNE positive.
Is Perry Shieh, MD, PhD currently recruiting for clinical trials?
Yes, Perry Shieh, MD, PhD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Perry Shieh, MD, PhD has studied deeply?
Yes, Perry Shieh, MD, PhD has studied treatments such as Placebo, Tideglusib, Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD).
What is the best way to schedule an appointment with Perry Shieh, MD, PhD?
Apply for one of the trials that Perry Shieh, MD, PhD is conducting.
What is the office address of Perry Shieh, MD, PhD?
The office of Perry Shieh, MD, PhD is located at: David Geffen School of Medicine at UCLA, Los Angeles, California 90095 United States. This is the address for their practice at the David Geffen School of Medicine at UCLA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.